Omeros (OMER)

While the concept of short-squeeze stocks has been all the rage throughout most of the pandemic-disruption cycle, we may have been doing this all wrong.…

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Oct 18, 2021

Welcome back, trader! I hope the weekend served you well because we've got pre-market stock movers to start off Monday with!

OMER Stock: Why Little-Known Omeros Is Absolutely Plunging Today

By Chris MacDonald, InvestorPlace Contributor Oct 1, 2021

Today, some rather unfortunate news has come to light regarding one of Omeros' prospective drugs, taking OMER stock 40% lower.

Best ETFs for 2018: Don’t Sweat This Quarter for the SBIO ETF

By Todd Shriber, InvestorPlace Contributor Sep 28, 2018

On a year-to-date basis, SBIO still looks good, up 14.30%, or 310 basis points better than the Nasdaq Biotechnology Index. Year-to-date, SBIO is also outpacing the equal-weight S&P Biotechnology Select Industry Index.

Omeros’ (OMER) Robust Sales Growth Make it a Buy at recent price of $11.24

By Portfolio Grader Feb 15, 2018

The a Buy rating for OMER is based on the Portfolio Grader stock evaluator. The methodology for investing incorporated in this analytical tool researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current Portfolio Grader recommendation on the shares has been in place for 7 months.

Omeros (OMER)

OMER Stock Earnings: Omeros Misses EPS for Q2 2024

OMER Stock Earnings: Omeros Misses EPS for Q1 2024

OMER Stock Earnings: Omeros Misses EPS for Q4 2023

Sleeping Giants: 3 Picks With Massive Upside by Mid-Decade

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Omeros (OMER)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

OMER Stock Predictions, Articles, and Omeros News

Subscriber Sign in